Mathias Karlsson Joins Capitainer as Chief Medical Officer

Capitainer has hired Mathias Karlsson as chief medical officer as part of an initiative to strengthen the team with additional medical expertise.

Karlsson is a qualified physician and an entrepreneur with solid experience in medical technology, life science, and business development. He joins Capitainer from his current role as Equalis CEO. “We’re extremely pleased to be able to welcome Mathias Karlsson to the Capitainer team as our new chief medical officer. His extensive knowledge and expertise within healthcare, diagnostics and medical technology, combined with his experience as an entrepreneur, are exceedingly valuable to Capitainer’s future development,” Capitainer CEO Christopher Aulin said.
 
Capitainer has developed a technology for self-sampling that could gain significant importance within remote care and precision medicine. The company is working to establish itself as a leading supplier of self-sampling solutions with clinical accuracy. 
 
Before his tenure as Equalis CEO, Karlsson was chief medical officer for the Nordics at IBM, with a focus on IT solutions forhealthcare services. Prior to that, he was the head of Outpatient care at the County of Värmland. Karlsson also has worked with the development and commercialization teams for numerous person-centred care products and as founder of the companies Calmark and Hemcheck.
 
The recruitment of Mathias Karlsson as CMO further strengthens Capitainer’s medical expertise while also supplementing the company’s existing technical expertise. In addition, the recruitment expands the company’s network, enable the firm to reach more operative clinics. Karlsson will assume his new role at Capitainer on Sept. 1.
 
“I’m really looking forward to joining Capitainer. The company already holds a strong market position, and I believe that its products for self-sampling can be of considerable importance to patients and healthcare personnel as well as within personalised medicine and remote care,” Karlsson stated. “My role at Capitainer is to be the patient’s voice in the company’s management team so that we can strive to ensure that Capitainer’s products deliver not only greater precision and accuracy, but also significant value to chronically ill patients, children and the increasingly large elderly population, in a cost-effective manner for healthcare providers.” 
 
Capitainer AB is a Swedish medtech company founded in 2016 that develops and sells intelligent solutions for self-sampling of blood, plasma, and urine. The company has developed technologies for collecting an exact amount of fluid and then allowing it to dry. The sample card can be sent with regular mail to laboratories without needing refrigerated transports or special packaging. The precision and accuracy in Capitainer’s samples perform on the same level as established pipetting methods. The products can be applied within several market segments, for instance, clinical biomarkers, therapeutic drug monitoring, genomics, drug development, drug abuse and doping testing, and R&D and clinical studies.